Furthermore, EdU incorporation assays demonstrated a pronounced decrease in proliferating tumour cells in the siRNA‐treated group (p < 0.01), reinforcing PTGER4's regulatory influence on cell cycle progression and mitotic activity. The gene discussed is PTGER4; the disease is neoplasm.